人福醫藥(600079.SH):百年康鑫獲GMP證書
格隆匯1月8日丨人福醫藥(600079.SH)公佈,公司全資子公司河南百年康鑫藥業有限公司(以下簡稱“百年康鑫”)於近日收到河南省藥品監督管理局頒發的《藥品GMP證書》。認證範圍:片劑、硬膠囊劑、顆粒劑、丸劑(蜜丸、水丸、滴丸)(含中藥前處理及提取)。
截至目前,百年康鑫本次GMP復認證的累計投入約為人民幣100萬元,預計片劑產能為600萬盒/年、硬膠囊劑產能為750萬盒/年、顆粒劑產能為750萬盒/年、丸劑產能為750萬盒/年。本次GMP復認證所涉及的主要產品為黃連上清片等。
黃連上清片功能主治清熱通便,散風止痛;適用於風熱上攻、肺胃熱盛所致的頭暈目眩、暴發火眼、牙齒疼痛、口舌生瘡、咽喉腫痛、耳痛耳鳴、大便祕結、小便短赤。根據國家藥品監督管理局網站顯示,目前全國有91家企業獲得該產品的生產批文。根據米內網數據統計,2018年度黃連上清片在我國城市公立醫院及城市零售藥店的銷售額約為人民幣3億元,主要生產廠商包括雲南白藥集團股份有限公司、太極集團重慶桐君閣藥廠有限公司、仲景宛西製藥股份有限公司等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.